90 related articles for article (PubMed ID: 14746021)
21. Cervical cancer: the second-generation vaccines move forward.
Tuma RS
J Natl Cancer Inst; 2009 Jun; 101(11):774-5. PubMed ID: 19470948
[No Abstract] [Full Text] [Related]
22. Toward vaccines against cervical cancer.
Jansen KU
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):228-32. PubMed ID: 15603257
[TBL] [Abstract][Full Text] [Related]
23. Vaccines against human papillomavirus: perspectives for controlling cervical cancer.
García Carrancá A; Galván SC
Expert Rev Vaccines; 2007 Aug; 6(4):497-510. PubMed ID: 17669005
[TBL] [Abstract][Full Text] [Related]
24. [Introduction of vaccination against human papillomavirus in developing countries: update and perspectives].
Hessel L
Med Trop (Mars); 2009 Aug; 69(4):323-6. PubMed ID: 19725378
[TBL] [Abstract][Full Text] [Related]
25. Coming soon: cervical cancer vaccines, and an array of public health issues.
McNeil C
J Natl Cancer Inst; 2006 Apr; 98(7):432-4. PubMed ID: 16595772
[No Abstract] [Full Text] [Related]
26. Natural history and epidemiology of HPV infection and cervical cancer.
Castellsagué X
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus vaccine.
Suba EJ; Raab SS;
N Engl J Med; 2007 Sep; 357(11):1155; author reply 1155-6. PubMed ID: 17874469
[No Abstract] [Full Text] [Related]
28. New paradigm for prevention of cervical cancer.
Kaufmann AM; Schneider A
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):25-9. PubMed ID: 16973254
[TBL] [Abstract][Full Text] [Related]
29. Customizing anticancer strategies to local needs.
Webb S
J Natl Cancer Inst; 2009 Jun; 101(12):842-4. PubMed ID: 19509362
[No Abstract] [Full Text] [Related]
30. Reducing the worldwide burden of cancer.
Markman M
Oncology; 2007; 73(1-2):1. PubMed ID: 18332647
[No Abstract] [Full Text] [Related]
31. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
Misra JS; Gupta HP; Das V
Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
[TBL] [Abstract][Full Text] [Related]
32. The burden of cervical cancer in south-east Europe at the beginning of the 21st century.
Arbyn M; Primic-Zakelj M; Raifu AO; Grce M; Paraskevaidis E; Diakomanolis E; Kesić V; Nicula FA; Suteu O; von Karsa L
Coll Antropol; 2007 Apr; 31 Suppl 2():7-10. PubMed ID: 17600932
[TBL] [Abstract][Full Text] [Related]
33. [Vaccination against cervical cancer and diseases caused by Human Papillomavirus].
Bornstein J; Tuma R; Zarfati D; Ophir E
Harefuah; 2007 Oct; 146(10):764-9, 814. PubMed ID: 17990391
[TBL] [Abstract][Full Text] [Related]
34. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
35. Making the case for cervical cancer prevention: what about equity?
Tsu VD; Levin CE
Reprod Health Matters; 2008 Nov; 16(32):104-12. PubMed ID: 19027628
[TBL] [Abstract][Full Text] [Related]
36. [Challenges to implement strategies for the primary and secondary prevention of cervical cancer in Mexico].
Lazcano-Ponce E; Allen B; Palacio-Mejía LS; Hernández-Avila M
Gac Med Mex; 2006; 142 Suppl 2():43-9. PubMed ID: 19031678
[TBL] [Abstract][Full Text] [Related]
37. Cervical cancer prevention in the human papilloma virus vaccine era.
Ghazal-Aswad S
Ann N Y Acad Sci; 2008 Sep; 1138():253-6. PubMed ID: 18837904
[TBL] [Abstract][Full Text] [Related]
38. Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
Dillner L; Pagliusi S; Bray F; Lorincz A; Kjaer SK; Anttila A; Iversen OE; Dillner J; Lehtinen M; Paavonen J
Acta Obstet Gynecol Scand; 2008; 87(5):489-98. PubMed ID: 18446530
[TBL] [Abstract][Full Text] [Related]
39. Cervical cancer: treatment challenges in the developing world.
Thomas G
Radiother Oncol; 2006 May; 79(2):139-41. PubMed ID: 16684573
[No Abstract] [Full Text] [Related]
40. Human papillomavirus vaccine: waiting for a miracle.
MacDonald N; Hébert PC
CMAJ; 2007 Aug; 177(5):433, 435. PubMed ID: 17724313
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
